Trial intelligence / Profile preview

Cerebrolysin for Post-COVID-19 Smell and Taste Loss

NCT04830943Phase 3Completed

Sponsor
Assiut University
Start
Aug 2020
Primary completion
Sep 2021
Modality
Native Peptides
Countries
1
01

Overview

A Phase 3 trial of cerebrolysin in anosmia, Ageusia, sponsored by Assiut University. Started Aug 2020; status: completed.

02

Drugs

cerebrolysin
03

Conditions

anosmiaAgeusia

Beyond the preview

Go deeper on NCT04830943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04830943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call